Dealing in Securities by a Prescribed Officer
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively "Aspen" or "the Group")
DEALING IN SECURITIES BY A PRESCRIBED OFFICER
In compliance with paragraphs 6.77 to 6.80 of the Listings Requirements of the JSE Limited,
shareholders are advised of the dealings in securities as set out below:
Deferred bonus shares, awarded in 2022, 2023, 2024 and 2025 in terms of the Aspen South African
Management Deferred Incentive Bonus Scheme, have vested on an accelerated basis and have been
delivered to the undermentioned prescribed officer.
PRESCRIBED OFFICER
Name : Michael Guy Attridge
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 23 June 2026
Nature of transaction : Off-market delivery of deferred incentive bonus shares
Number of securities vested : 44,030
Price on vesting : R140.529
Value of vesting : R6,187,492
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Yes
Durban
25 June 2026
Sponsor
Investec Bank Limited
Date: 25-06-2026 04:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.